79140EGP
- Active ingredient
- pembrolizumab
- Strength
- 100mg/4ml
- Form
- vial
- Manufacturer
- merck sharp & dohme > ramco
- Route
- injection
Uses
Immune checkpoint inhibitor used to treat multiple advanced or metastatic cancers.
Do not use if
Known serious hypersensitivity to pembrolizumab or formulation components.
Side effects
Fatigue, rash, diarrhea, nausea, and immune-mediated adverse reactions may occur.
Warnings
May cause serious immune-mediated toxicities affecting multiple organs.
How it works
Monoclonal antibody targeting PD-1 to enhance antitumor immune responses.
Storage
Store refrigerated at 2–8°C.